Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Susan Estabrooks Hahn, Simon Tavaré, Mike Aicher

Premium

The American Board of Genetic Counseling has appointed Susan Estabrooks Hahn of the Miller School of Medicine at the University of Miami to be its president-elect.

Hahn is an instructor at the John T. Macdonald Foundation Department of Human Genetics at the Miller School. Hahn will serve as president-elect for ABCG in 2013 and as president in 2014.

The ABCG is a credentialing organization that provides certification for the genetic counseling profession in the US and Canada.

Hahn also is assistant director of communications, compliance, and ethics at the Hussman Institute for Human Genomics.


Simon Tavaré has been named director of the Cancer Research UK Cambridge Institute. Tavaré has been a professor in the oncology department and a professor of applied mathematics and theoretical physics at the University of Cambridge since 2003. He is also a research professor at the University of Southern California, where he holds the George and Louise Kawamoto chair in biological sciences.

His work has focused on statistical methods for studying cancer that rely on population genetics, cancer genomics, and DNA sequencing.


Omicia has appointed Mike Aicher to CEO and to the company's board of directorss, taking over for Martin Reese, a co-founder of the company. Reese is now Omicia's president and chief scientific officer. Previously, Aicher was CEO of the National Genetics Institute, a company that he co-founded that became a wholly owned subsidiary of Laboratory Corporation of America. Most recently, he led LabCorp's western division and was responsible for the company's esoteric business units. He holds a BS in business administration from the University of Redlands and an MBA in economics from Columbus University.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.